Status:
UNKNOWN
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
Lead Sponsor:
Assiut University
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
20-60 years
Brief Summary
Acute pancreatitis (AP) is a multifactorial disease. AP represents a significant number of hospital admissions. Most of the patients are admitted in an acute setting. Early identification of its etiol...
Detailed Description
Acute pancreatitis is the most common pancreatic disorder. Although acute pancreatitis is a benign disease, it often progresses to a serious state, and mortality is still high. Autoimmune pancreatitis...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of acute pancreatitis.
- Patients of age 20 years or more who are willing to participate in the study and give their consent for same.
Exclusion
- with a history of severe liver disease,
- sepsis
- Chest disease.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03830073
Start Date
March 1 2019
End Date
June 20 2019
Last Update
February 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.